4SC AG (FRA:VSC) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is 4SC AG Asset Impairment Charge?

4SC AG's Asset Impairment Charge for the six months ended in Jun. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

4SC AG Asset Impairment Charge Historical Data

The historical data trend for 4SC AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Asset Impairment Charge Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

4SC AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

4SC AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

4SC AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of 4SC AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (FRA:VSC) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstrasse 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG Headlines

No Headlines